Wexford Capital’s Avalo Therapeutics AVTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-5
Closed -$41K 208
2020
Q4
$41K Buy
+5
New +$41K 0.01% 228